Abstract #1512

Early cancer signs detected by glucoCEST

Francisco Torrealdea¹, Marilena Rega¹, Sebastian Brandner¹, David Thomas¹, and Xavier Golay¹

¹Brain Repair & Rehabilitation, UCL Institute of Neurology, London, United Kingdom

In this work, the feasibility of using glucoCEST as a tool for early detection of primary brain tumours is explored. Mice bearing xenograft glioblastoma tumours were scanned longitudinally using a glucoCEST protocol. The results suggest the intriguing possibility that glucoCEST contrast may be able to detect the presence of cancer at very early stage.

This abstract and the presentation materials are available to members only; a login is required.

Join Here